Results 51 to 60 of about 1,178,773 (316)

Enzyme-Expression-and-Purification

open access: yes, 2019
As a pioneer of the enzymes manufacturer industry, Creative Enzymes is known as its specialization and consolidates its leader's position in this field gradually since the year founded by always taking initiative in this field.
Iva Colter (6713138)
core   +1 more source

Purification of Glomerulopressin

open access: yesExperimental Biology and Medicine, 1987
The present investigation was undertaken to attempt the purification of glomerulopressin. Isolated rat livers were perfused with Krebs-Ringer bicarbonate, and the perfusate was concentrated at reduced pressure, extracted with n-butanol, and subjected to thin-layer chromatography (TLC) with different solvent systems.
R, Bonetto   +3 more
openaire   +2 more sources

Experience With Performing Rheocarna Therapy via the Single‐Needle Method for Treatment of Chronic Limb‐Threatening Ischemia

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This study investigated the safety and efficacy of single‐needle Rheocarna therapy for chronic limb‐threatening ischemia (CLTI) with wounds. Methods Six patients with CLTI involving ulcers unresponsive to revascularization underwent single‐needle Rheocarna treatment.
Yasutaka Yamauchi   +9 more
wiley   +1 more source

The use of phenyl-Sepharose for the affinity purification of proteinases

open access: yes, 1993
Phenyl-Sepharose is most often used as an adsorbent for hydrophobic interaction chromatography (HIC). We report on its effective use for the affinity purification of some extracellular thermostable proteinases from bacterial sources.
Prescott, Mark   +3 more
core   +1 more source

THE PURIFICATION OF MERCURY [PDF]

open access: yesSchool Science and Mathematics, 1902
n ...
openaire   +1 more source

Prognosis of Long‐Term Continuous Renal Replacement Therapy and the Impact of Combined Continuous Intravenous Sodium Infusion Therapy

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Patients requiring long‐term continuous renal replacement therapy (CRRT) generally have poor prognoses. This study evaluated whether adding continuous intravenous sodium infusion (cIVNa) is associated with improved hemodynamics and outcomes in patients undergoing long‐term CRRT for ≥ 7 days.
Akinori Yamaguchi   +6 more
wiley   +1 more source

Latent profiles of falls self-awareness and associated factors in older maintenance hemodialysis patients

open access: yesScientific Reports
Falls are a significant concern for elderly Maintenance Hemodialysis (MHD) patients, with a rising fall-related mortality rate observed over the past decade.
Jun Xu   +3 more
doaj   +1 more source

Effects of different potassium-lowering regimens on acute hyperkalemia in hemodialysis patients: a real-world, retrospective study

open access: yesJournal of Translational Medicine, 2022
Background Hyperkalemia is a common and potentially life-threatening electrolyte disorder in maintenance hemodialysis (MHD) patients. This study aimed to evaluate the efficacy and safety of potassium-lowering regimens during treatment of acute ...
Lan Yao   +6 more
doaj   +1 more source

Organoids in pediatric cancer research

open access: yesFEBS Letters, EarlyView.
Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley   +1 more source

Environmental chitinous materials as adsorbents for one-step purification of protease and chitosanase

open access: yes, 2014
We describe the use of chitinous materials as adsorbents for purification of protease and chitosanase from bromelain solution and chitosanase from culture supernatants of three bacterial strains: Serratia marcescens TKU011, Bacillus cereus TKU022 and ...
Wang, San-Lang; Nguyen, Anh Dzung   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy